142 related articles for article (PubMed ID: 11185523)
21. Twenty-three novel BRCA1 and BRCA2 sequence alterations in breast and/or ovarian cancer families in Southern Germany.
Meyer P; Voigtlaender T; Bartram CR; Klaes R
Hum Mutat; 2003 Sep; 22(3):259. PubMed ID: 12938098
[TBL] [Abstract][Full Text] [Related]
22. Women with family breast cancer history have no increased risk of ovarian cancer.
Health News; 2006 Feb; 12(2):9. PubMed ID: 16456923
[No Abstract] [Full Text] [Related]
23. A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families.
Vahteristo P; Eerola H; Tamminen A; Blomqvist C; Nevanlinna H
Br J Cancer; 2001 Mar; 84(5):704-8. PubMed ID: 11237395
[TBL] [Abstract][Full Text] [Related]
24. Implication of BRCA1 gene in breast cancer.
Kachhap SK; Ghosh SN
Indian J Exp Biol; 2001 May; 39(5):391-400. PubMed ID: 11510120
[TBL] [Abstract][Full Text] [Related]
25. Role of BRCA gene dysfunction in breast and ovarian cancer predisposition.
Scully R
Breast Cancer Res; 2000; 2(5):324-30. PubMed ID: 11250724
[TBL] [Abstract][Full Text] [Related]
26. BRCA1 and BRCA2 proteins: roles in health and disease.
Duncan JA; Reeves JR; Cooke TG
Mol Pathol; 1998 Oct; 51(5):237-47. PubMed ID: 10193517
[TBL] [Abstract][Full Text] [Related]
27. Interactions between BRCA proteins and DNA structure.
Scully R
Exp Cell Res; 2001 Mar; 264(1):67-73. PubMed ID: 11237524
[No Abstract] [Full Text] [Related]
28. [Inherited breast and ovarian cancers].
Gerdes AM; Ejlertsen B
Ugeskr Laeger; 2006 Jun; 168(24):2367-9. PubMed ID: 16822422
[TBL] [Abstract][Full Text] [Related]
29. Analysis of breast cancer susceptibility genes BRCA1 and BRCA2 in Thai familial and isolated early-onset breast and ovarian cancer.
Patmasiriwat P; Bhothisuwan K; Sinilnikova OM; Chopin S; Methakijvaroon S; Badzioch M; Padungsutt P; Vattanaviboon P; Vattanasapt V; Szabo C; Saunders GF; Goldgar D; Lenoir GM
Hum Mutat; 2002 Sep; 20(3):230. PubMed ID: 12203997
[TBL] [Abstract][Full Text] [Related]
30. [In familial breast or ovarian carcinoma: normal cancer prevention is not enough].
Riem L
MMW Fortschr Med; 2004 Apr; 146(15):12. PubMed ID: 15373015
[No Abstract] [Full Text] [Related]
31. The RAD51 135 G>C polymorphism modifies breast cancer and ovarian cancer risk in Polish BRCA1 mutation carriers.
Jakubowska A; Gronwald J; Menkiszak J; Górski B; Huzarski T; Byrski T; Edler L; Lubiñski J; Scott RJ; Hamann U
Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):270-5. PubMed ID: 17301259
[TBL] [Abstract][Full Text] [Related]
32. [Revocation of the BRCA1 patents by the European Office of Patents: a victory over a rights abuse].
Stoppa-Lyonnet D; Lenoir G
Bull Cancer; 2005 Apr; 92(4):410-1. PubMed ID: 15888396
[No Abstract] [Full Text] [Related]
33. Germline mutations in the BRCA1 gene predisposing to breast and ovarian cancers in Upper Silesia population.
Grzybowska E; Siemińska M; Zientek H; Kalinowska E; Michalska J; Utracka-Hutka B; Rogozińska-Szczepka J; Kaźmierczak-Maciejewska M
Acta Biochim Pol; 2002; 49(2):351-6. PubMed ID: 12362976
[TBL] [Abstract][Full Text] [Related]
34. Genetic counseling in hereditary breast/ovarian cancer in Israel: psychosocial impact and retention of genetic information.
DiCastro M; Frydman M; Friedman I; Shiri-Sverdlov R; Papa MZ; Goldman B; Friedman E
Am J Med Genet; 2002 Aug; 111(2):147-51. PubMed ID: 12210341
[TBL] [Abstract][Full Text] [Related]
35. Does the search for large genomic rearrangements impact BRCAPRO carrier prediction?
Capalbo C; Buffone A; Vestri A; Ricevuto E; Rinaldi C; Zani M; Ferraro S; Frati L; Screpanti I; Gulino A; Giannini G
J Clin Oncol; 2007 Jun; 25(18):2632-4; author reply 2634-5. PubMed ID: 17577048
[No Abstract] [Full Text] [Related]
36. G1738R is a BRCA1 founder mutation in Greek breast/ovarian cancer patients: evaluation of its pathogenicity and inferences on its genealogical history.
Anagnostopoulos T; Pertesi M; Konstantopoulou I; Armaou S; Kamakari S; Nasioulas G; Athanasiou A; Dobrovic A; Young MA; Goldgar D; Fountzilas G; Yannoukakos D
Breast Cancer Res Treat; 2008 Jul; 110(2):377-85. PubMed ID: 17902052
[TBL] [Abstract][Full Text] [Related]
37. Cancer research. Transatlantic war over BRCA1 patent.
Balter M
Science; 2001 Jun; 292(5523):1818. PubMed ID: 11397923
[No Abstract] [Full Text] [Related]
38. In search of the tumour-suppressor functions of BRCA1 and BRCA2.
Scully R; Livingston DM
Nature; 2000 Nov; 408(6811):429-32. PubMed ID: 11100717
[TBL] [Abstract][Full Text] [Related]
39. Structure-based assessment of missense mutations in human BRCA1: implications for breast and ovarian cancer predisposition.
Mirkovic N; Marti-Renom MA; Weber BL; Sali A; Monteiro AN
Cancer Res; 2004 Jun; 64(11):3790-7. PubMed ID: 15172985
[TBL] [Abstract][Full Text] [Related]
40. Novel and common BRCA1 mutations in familial breast/ovarian cancer patients from Lithuania.
Janavicius R; Pepalyte I; Kucinskas V
Breast Cancer Res Treat; 2009 Sep; 117(2):467-9. PubMed ID: 18763032
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
